The Brief

The FDA has authorized another generic variation of mifepristone.

Drugmaker Evita Solutions says the version of this drug will be released in 2026.

Last year, the Supreme Court refused to limit access to mifepristone.

Food and Drug Administration officials have approved another generic version of the abortion pill mifepristone.

The Associated Press reported that drugmaker Evita Solutions shared on its website that the FDA authorized its low-cost form of the pill, which is approved to end pregnancies through 10 weeks.

RELATED: RFK Jr. launches FDA safety review of abortion pill mifepristone

An FDA spokesperson told the AP that the agency "has very limited discretion in deciding whether to approve a generic drug," and added that FDA officials do not "endorse any produc

See Full Page